mCTA version 8 use letter final

Projects

Letter template for sites and sponsors to confirm their adoption of the mCTA

Author/Presenter: CCTCC

https://www.cctcc.ca/wp-content/uploads/2018/08/mCTA-version-8-use-letter-final-draft.docx

Latest Case Studies

View Detail

Clinical trials transparency in the Americas: the need to coordinate regulatory spheres

BMJ 2018; 362:k2493 Author/Presenter: Trudo Lemmens, professor and Scholl chair in health law and policy, and Carlos Herrera Vacaflor, researcher

View Detail
square

Investment Case – “Clinical Trials – The Canadian Advantage” – 2018

The case for running clinical trials in Canada, advantages and information (English, pdf format) Author/Presenter: CCTCC